Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
Global Metrics

Ligand Pharmaceuticals Net Income 2006-2020 | LGND

For a detailed definition, formula and example for Net Income, check out our new background page here.
Ligand Pharmaceuticals net income from 2006 to 2020. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  
Ligand Pharmaceuticals Annual Net Income
(Millions of US $)
2020 $-3
2019 $629
2018 $143
2017 $13
2016 $-2
2015 $230
2014 $12
2013 $11
2012 $-1
2011 $10
2010 $-10
2009 $-2
2008 $-98
2007 $282
2006 $-32
2005 $-36
Ligand Pharmaceuticals Quarterly Net Income
(Millions of US $)
2020-12-31 $6
2020-09-30 $-7
2020-06-30 $22
2020-03-31 $-24
2019-12-31 $-7
2019-09-30 $-15
2019-06-30 $-14
2019-03-31 $666
2018-12-31 $-42
2018-09-30 $67
2018-06-30 $73
2018-03-31 $45
2017-12-31 $-7
2017-09-30 $8
2017-06-30 $6
2017-03-31 $5
2016-12-31 $-3
2016-09-30 $1
2016-06-30 $-6
2016-03-31 $7
2015-12-31 $6
2015-09-30 $199
2015-06-30 $24
2015-03-31 $1
2014-12-31 $7
2014-09-30 $1
2014-06-30 $2
2014-03-31 $2
2013-12-31 $2
2013-09-30 $2
2013-06-30 $6
2013-03-31 $1
2012-12-31 $1
2012-09-30 $-0
2012-06-30 $-3
2012-03-31 $1
2011-12-31 $5
2011-09-30 $-4
2011-06-30 $-0
2011-03-31 $10
2010-12-31 $5
2010-09-30 $-12
2010-06-30 $-0
2010-03-31 $-3
2009-12-31 $3
2009-09-30 $2
2009-06-30 $-2
2009-03-31 $-5
2008-12-31 $-70
2008-09-30 $-18
2008-06-30 $-6
2008-03-31 $-4
2007-12-31 $6
2007-09-30 $1
2007-06-30 $0
2007-03-31 $274
2006-12-31 $141
2006-09-30 $-15
2006-06-30 $-16
2006-03-31 $-142
2005-12-31 $-3
2005-09-30 $-6
2005-06-30 $-9
2005-03-31 $-18
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.438B $0.186B
Ligand Pharmaceuticals Incorporated discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas of cancer, pain, skin diseases, men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology, primarily related to intracellular receptors.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $149.213B 15.61
Bristol Myers Squibb (BMY) United States $147.618B 10.26
CSL (CSLLY) Australia $92.772B 0.00
Gilead Sciences (GILD) United States $83.576B 9.36
Moderna (MRNA) United States $62.794B 0.00
Illumina (ILMN) United States $58.158B 88.53
Vertex Pharmaceuticals (VRTX) United States $56.982B 24.33
Regeneron Pharmaceuticals (REGN) United States $54.039B 17.66
Biogen (BIIB) United States $41.618B 8.32
BioNTech SE (BNTX) Germany $37.721B 976.13
Alexion Pharmaceuticals (ALXN) United States $36.791B 14.26
BeiGene (BGNE) Cayman Islands $26.846B 0.00
Seagen (SGEN) United States $26.246B 44.96
Genmab (GMAB) Denmark $23.441B 32.79
Genmab (GNMSF) Denmark $22.296B 5.28
Exact Sciences (EXAS) United States $21.241B 0.00
Horizon Therapeutics Public (HZNP) Ireland $20.404B 23.41
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.071B 0.00
Incyte (INCY) United States $18.595B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.932B 57.06
Bio-Techne Corp (TECH) United States $15.982B 91.54
Alnylam Pharmaceuticals (ALNY) United States $15.959B 0.00
Novavax (NVAX) United States $15.374B 0.00
Guardant Health (GH) United States $15.011B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.446B 115.14
ARGENX SE-ADR (ARGX) Netherlands $14.280B 0.00
Zai Lab (ZLAB) China $13.357B 0.00
QIAGEN (QGEN) Netherlands $11.910B 24.30
Repligen (RGEN) United States $11.611B 127.71
CRISPR Therapeutics AG (CRSP) Switzerland $9.177B 0.00
Mirati Therapeutics (MRTX) United States $7.998B 0.00
Exelixis (EXEL) United States $7.674B 70.03
AbCellera Biologics (ABCL) $7.473B 0.00
Fate Therapeutics (FATE) United States $7.332B 0.00
Acceleron Pharma (XLRN) United States $7.273B 0.00
Ultragenyx Pharmaceutical (RARE) United States $7.029B 0.00
Ascendis Pharma (ASND) Denmark $6.720B 0.00
Halozyme Therapeutics (HALO) United States $6.711B 52.03
Denali Therapeutics (DNLI) United States $6.331B 201.27
Vir Biotechnology (VIR) United States $6.202B 0.00
Twist Bioscience (TWST) United States $6.150B 0.00
Sarepta Therapeutics (SRPT) United States $5.663B 0.00
Adaptive Biotechnologies (ADPT) United States $5.611B 0.00
NeoGenomics (NEO) United States $5.588B 682.00
Blueprint Medicines (BPMC) United States $5.366B 17.67
Galapagos (GLPG) Belgium $5.219B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $4.881B 15.35
Biohaven Pharmaceutical Holding (BHVN) United States $4.569B 0.00
Intellia Therapeutics (NTLA) United States $4.565B 0.00
Beam Therapeutics (BEAM) United States $4.439B 0.00
Certara (CERT) United States $4.181B 0.00
I-Mab (IMAB) China $4.088B 0.00
Arena Pharmaceuticals (ARNA) United States $4.028B 0.00
Apellis Pharmaceuticals (APLS) United States $3.696B 0.00
Legend Biotech (LEGN) United States $3.554B 0.00
Emergent Biosolutions (EBS) United States $3.516B 8.36
Atea Pharmaceuticals (AVIR) United States $3.503B 0.00
Insmed (INSM) United States $3.336B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.329B 0.00
SpringWorks Therapeutics (SWTX) United States $3.328B 0.00
Reata Pharmaceuticals (RETA) United States $3.231B 0.00
Alkermes (ALKS) Ireland $3.210B 0.00
Berkeley Lights (BLI) United States $3.099B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $3.026B 42.81
Arvinas (ARVN) United States $3.026B 0.00
MorphoSys AG (MOR) Germany $2.960B 45.00
Seer (SEER) $2.943B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.645B 0.00
Amicus Therapeutics (FOLD) United States $2.586B 0.00
Global Blood Therapeutics (GBT) United States $2.565B 0.00
Intra-Cellular Therapies (ITCI) United States $2.473B 0.00
Vericel (VCEL) United States $2.464B 1069.20
Instil Bio (TIL) United States $2.367B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.325B 0.00
Editas Medicine (EDIT) United States $2.322B 0.00
Arcus Biosciences (RCUS) United States $2.265B 0.00
ALX Oncology Holdings (ALXO) United States $2.185B 0.00
Sorrento Therapeutics (SRNE) United States $2.120B 0.00
Myriad Genetics (MYGN) United States $2.049B 0.00
PHARMA MAR SA (PHMMF) Spain $2.046B 0.00
NGM Biopharmaceuticals (NGM) United States $1.978B 0.00
Amarin (AMRN) Ireland $1.948B 0.00
Revance Therapeutics (RVNC) United States $1.913B 0.00
Bluebird Bio (BLUE) United States $1.871B 0.00
Cytokinetics (CYTK) United States $1.810B 0.00
Inovio Pharmaceuticals (INO) United States $1.798B 0.00
Seres Therapeutics (MCRB) United States $1.794B 0.00
Kymera Therapeutics (KYMR) United States $1.785B 0.00
Heska (HSKA) United States $1.769B 0.00
Morphic Holding (MORF) United States $1.761B 0.00
Genetron Holdings (GTH) China $1.735B 0.00
Sangamo Therapeutics (SGMO) United States $1.657B 0.00
PureTech Health (PRTC) United States $1.652B 0.00
Precigen (PGEN) United States $1.612B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.609B 0.00
BioAtla (BCAB) United States $1.585B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.582B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.560B 0.00
Travere Therapeutics (TVTX) United States $1.524B 0.00
Castle Biosciences (CSTL) United States $1.515B 0.00
Bionano Genomics (BNGO) United States $1.499B 0.00
Codexis (CDXS) United States $1.474B 0.00
UniQure (QURE) Netherlands $1.463B 0.00
Alector (ALEC) United States $1.433B 0.00
Keros Therapeutics (KROS) United States $1.426B 0.00
REGENXBIO (RGNX) United States $1.415B 0.00
Zealand Pharma (ZEAL) Denmark $1.384B 0.00
Cara Therapeutics (CARA) United States $1.371B 343.63
Nurix Therapeutics (NRIX) United States $1.311B 0.00
C4 Therapeutics (CCCC) United States $1.310B 0.00
Shattuck Labs (STTK) United States $1.233B 0.00
Zymeworks (ZYME) Canada $1.223B 0.00
MiMedx (MDXG) United States $1.205B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.191B 0.00
Northwest Biotherapeutics (NWBO) United States $1.183B 0.00
Repare Therapeutics (RPTX) Canada $1.181B 0.00
Protagonist Therapeutics (PTGX) United States $1.170B 0.00
Zealand Pharma (ZLDPF) Denmark $1.167B 0.00
Avid Bioservices (CDMO) United States $1.156B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.136B 0.00
Mesoblast (MESO) Australia $1.109B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.109B 0.00
Scholar Rock Holding (SRRK) United States $1.103B 0.00
Mersana Therapeutics (MRSN) United States $1.098B 0.00
MannKind (MNKD) United States $1.054B 0.00
Coherus BioSciences (CHRS) United States $1.043B 8.44
Ocugen (OCGN) United States $1.038B 0.00
Nkarta (NKTX) United States $1.025B 0.00
Dynavax Technologies (DVAX) United States $1.024B 0.00
Pliant Therapeutics (PLRX) United States $1.007B 0.00
Prometheus Biosciences (RXDX) United States $0.984B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.963B 0.00
G1 THERAPEUTICS (GTHX) United States $0.951B 0.00
Celldex Therapeutics (CLDX) United States $0.938B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.908B 38.49
Prothena (PRTA) Ireland $0.901B 0.00
Curis (CRIS) United States $0.899B 0.00
Bolt Biotherapeutics (BOLT) United States $0.884B 0.00
Affimed (AFMD) Germany $0.881B 0.00
Adverum Biotechnologies (ADVM) United States $0.874B 0.00
Sutro Biopharma (STRO) United States $0.860B 0.00
Merus (MRUS) Netherlands $0.841B 0.00
Pharming Group (PHAR) Netherlands $0.824B 0.00
Epizyme (EPZM) United States $0.788B 0.00
Pharming Group (PHGUF) Netherlands $0.782B 20.83
Cellectis S.A (CLLS) France $0.781B 0.00
Cel-Sci (CVM) United States $0.758B 0.00
Avidity Biosciences (RNA) United States $0.756B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.734B 0.00
KaloBios Pharmaceuticals (HGEN) United States $0.724B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.711B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.704B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.690B 0.00
Inhibrx (INBX) United States $0.689B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.682B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.677B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.664B 0.00
VBI Vaccines (VBIV) United States $0.663B 0.00
Kadmon Holdings (KDMN) United States $0.658B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.647B 0.00
DBV Technologies S.A (DBVT) France $0.647B 0.00
Sinovac Biotech (SVA) China $0.640B 35.94
MeiraGTx Holdings (MGTX) United States $0.617B 0.00
IDEAYA Biosciences (IDYA) United States $0.611B 0.00
ALBIREO PHARMA (ALBO) United States $0.602B 0.00
AnaptysBio (ANAB) United States $0.600B 0.00
Clovis Oncology (CLVS) United States $0.593B 0.00
Adagene (ADAG) $0.584B 0.00
Anika Therapeutics (ANIK) United States $0.582B 193.33
Starpharma Holdings (SPHRY) Australia $0.566B 0.00
Compugen (CGEN) Israel $0.564B 0.00
Agenus (AGEN) United States $0.548B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.539B 0.00
CytomX Therapeutics (CTMX) United States $0.516B 0.00
RAPT THERAPTICS (RAPT) United States $0.513B 0.00
Inventiva S.A (IVA) France $0.513B 0.00
Neoleukin Therapeutics (NLTX) United States $0.510B 0.00
ChromaDex (CDXC) United States $0.493B 0.00
Precision BioSciences (DTIL) United States $0.486B 0.00
XBiotech (XBIT) United States $0.485B 0.00
Amryt Pharma (AMYT) United Kingdom $0.484B 0.00
AC Immune SA (ACIU) Switzerland $0.468B 0.00
Verastem (VSTM) United States $0.465B 0.00
Forte Biosciences (FBRX) United States $0.448B 0.00
Geron (GERN) United States $0.446B 0.00
Kala Pharmaceuticals (KALA) United States $0.431B 0.00
Gritstone Oncology (GRTS) United States $0.421B 0.00
Opthea (OPT) Australia $0.414B 0.00
Selecta Biosciences (SELB) United States $0.411B 0.00
ANI Pharmaceuticals (ANIP) United States $0.408B 11.38
Seelos Therapeutics (SEEL) United States $0.399B 0.00
XOMA (XOMA) United States $0.399B 88.60
Puma Biotechnology (PBYI) United States $0.395B 0.00
Angion Biomedica (ANGN) United States $0.392B 0.00
UROGEN PHARMA (URGN) United States $0.391B 0.00
Adicet Bio (ACET) United States $0.384B 0.00
AquaBounty Technologies (AQB) United States $0.383B 0.00
Fortress Biotech (FBIO) United States $0.381B 0.00
Fulcrum Therapeutics (FULC) United States $0.380B 0.00
Cue Biopharma (CUE) United States $0.376B 0.00
Syros Pharmaceuticals (SYRS) United States $0.375B 0.00
Athenex (ATNX) United States $0.373B 0.00
SESEN BIO, INC (SESN) United States $0.369B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.369B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.368B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.363B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.361B 0.00
Spero Therapeutics (SPRO) United States $0.361B 0.00
Athersys (ATHX) United States $0.357B 0.00
Bellus Health (BLU) Canada $0.345B 0.00
SQZ Biotechnologies (SQZ) United States $0.343B 0.00
Theratechnologies (THTX) Canada $0.337B 0.00
Innate Pharma S.A (IPHA) France $0.331B 0.00
BioDelivery Sciences (BDSI) United States $0.331B 13.12
Frequency Therapeutics (FREQ) United States $0.326B 0.00
Cogent Biosciences (COGT) United States $0.314B 0.00
HOOKIPA Pharma (HOOK) United States $0.314B 0.00
Talis Biomedical (TLIS) United States $0.312B 0.00
Oncobiologics (OTLK) United States $0.309B 0.00
Cardiff Oncology (CRDF) United States $0.304B 0.00
WAVE Life Sciences (WVE) Singapore $0.289B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.289B 0.00
Arbutus Biopharma (ABUS) United States $0.288B 0.00
CorMedix Inc (CRMD) United States $0.286B 0.00
PDL BioPharma (PDLI) United States $0.283B 0.00
Trevena (TRVN) United States $0.274B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.272B 0.00
Kamada (KMDA) Israel $0.268B 15.44
IBio (IBIO) United States $0.266B 0.00
Codiak BioSciences (CDAK) United States $0.262B 0.00
Kaleido Biosciences (KLDO) $0.258B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.257B 0.00
Protalix BioTherapeutics (PLX) Israel $0.250B 0.00
NextCure (NXTC) United States $0.250B 0.00
OVID THERAPEUTC (OVID) United States $0.237B 0.00
Cerecor (CERC) United States $0.209B 0.00
Prima BioMed (IMMP) Australia $0.206B 0.00
Checkpoint Therapeutics (CKPT) United States $0.202B 0.00
TELA Bio (TELA) United States $0.196B 0.00
Kindred Biosciences (KIN) United States $0.195B 0.00
VTv Therapeutics (VTVT) United States $0.194B 0.00
POXEL SA FRANCE (PXXLF) France $0.193B 0.00
OSMOTICA PHARM (OSMT) United States $0.190B 0.00
GENFIT S.A (GNFT) France $0.190B 0.00
Eton Pharmaceuticals (ETON) United States $0.189B 0.00
ADMA Biologics Inc (ADMA) United States $0.183B 0.00
LogicBio Therapeutics (LOGC) United States $0.181B 0.00
Aptinyx (APTX) United States $0.176B 0.00
Voyager Therapeutics (VYGR) United States $0.176B 4.92
Nicox SA (NICXF) France $0.172B 0.00
DiaMedica Therapeutics (DMAC) United States $0.170B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.170B 0.00
VolitionRX (VNRX) United States $0.167B 0.00
Chiasma (CHMA) United States $0.165B 0.00
INmune Bio (INMB) United States $0.165B 0.00
Strongbridge Biopharma (SBBP) United States $0.161B 0.00
Erytech Pharma SA (ERYP) France $0.157B 0.00
Clearside Biomedical (CLSD) United States $0.157B 0.00
X4 Pharmaceuticals (XFOR) United States $0.156B 0.00
Antibe Therapeutics (ATBPF) Canada $0.155B 0.00
Applied Genetic Technologies (AGTC) United States $0.155B 0.00
Enzo Biochem (ENZ) United States $0.152B 0.00
ObsEva SA (OBSV) Switzerland $0.150B 0.00
Biofrontera AG (BFRA) Germany $0.147B 0.00
Exicure (XCUR) United States $0.147B 0.00
Abeona Therapeutics (ABEO) United States $0.145B 0.00
Catalyst Biosciences (CBIO) United States $0.143B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.138B 0.00
Pluristem Therapeutics (PSTI) Israel $0.135B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.131B 0.00
Dyadic (DYAI) United States $0.131B 0.00
Palatin Technologies (PTN) United States $0.127B 0.00
Orgenesis (ORGS) United States $0.124B 253.50
Liquidia Technologies (LQDA) United States $0.123B 0.00
Synlogic (SYBX) United States $0.121B 0.00
Eyenovia (EYEN) United States $0.119B 0.00
Evofem Biosciences (EVFM) United States $0.118B 0.00
Aytu BioPharma (AYTU) United States $0.115B 0.00
Liminal BioSciences (LMNL) Canada $0.114B 0.00
Aptevo Therapeutics (APVO) United States $0.111B 0.00
TRACON Pharmaceuticals (TCON) United States $0.110B 0.00
Galena Biopharma (SLS) United States $0.108B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.108B 0.00
Evogene (EVGN) Israel $0.107B 0.00
Beyond Air (XAIR) United States $0.107B 0.00
Armata Pharmaceuticals (ARMP) United States $0.105B 0.00
Novogen (KZIA) Australia $0.102B 0.00
ARAVIVE, INC (ARAV) United States $0.102B 0.00
Ecology Coatings (ABVC) United States $0.099B 0.00
Lumos Pharma (LUMO) United States $0.098B 0.00
Cidara Therapeutics (CDTX) United States $0.098B 0.00
Leap Therapeutics (LPTX) United States $0.097B 0.00
Celyad SA (CYAD) Belgium $0.091B 0.00
PHASEBIO PHARMA (PHAS) United States $0.090B 0.00
Cyclerion Therapeutics (CYCN) United States $0.089B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.086B 0.00
Vascular Biogenics (VBLT) Israel $0.084B 0.00
Zosano Pharma (ZSAN) United States $0.082B 0.00
Cocrystal Pharma (COCP) United States $0.081B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.079B 0.00
Adocia (ADOCY) France $0.077B 0.00
Purple Biotech (PPBT) Israel $0.076B 0.00
Celsion (CLSN) United States $0.074B 0.00
AIkido Pharma (AIKI) United States $0.073B 0.00
CytRx (CYTR) United States $0.073B 0.00
Cleveland BioLabs (CBLI) United States $0.072B 0.00
Vaccinex (VCNX) United States $0.066B 0.00
Edesa Biotech (EDSA) Canada $0.065B 0.00
ARIDIS PHARMACT (ARDS) United States $0.064B 0.00
Emmaus Life Sciences (EMMA) United States $0.063B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.060B 0.00
ATyr Pharma (LIFE) United States $0.059B 0.00
BioCardia (BCDA) United States $0.057B 0.00
Genetic Technologies (GENE) Australia $0.057B 0.00
ZIVO Bioscience (ZIVO) United States $0.055B 0.00
Windtree Therapeutics (WINT) United States $0.055B 0.00
Organovo Holdings (ONVO) United States $0.054B 0.00
Advaxis (ADXS) United States $0.053B 0.00
AEterna Zentaris (AEZS) United States $0.053B 0.00
Alimera Sciences (ALIM) United States $0.053B 0.00
Appili Therapeutics (APLIF) Canada $0.053B 0.00
Pulmatrix (PULM) United States $0.052B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.052B 0.00
Soligenix (SNGX) United States $0.051B 0.00
AnPac Bio-Medical Science (ANPC) China $0.051B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.048B 0.00
Enveric Biosciences (ENVB) United States $0.047B 0.00
Timber Pharmaceuticals (TMBR) United States $0.046B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.046B 0.00
Yumanity Therapeutics (YMTX) United States $0.045B 0.00
Happiness Biotech Group (HAPP) China $0.045B 0.00
Cyclo Therapeutics (CYTH) United States $0.045B 0.00
Idera Pharmaceuticals (IDRA) United States $0.043B 0.00
Invo BioScience (INVO) United States $0.040B 0.00
Acorda Therapeutics (ACOR) United States $0.039B 0.59
Clene (CLNN) United States $0.038B 0.00
Vyant Bio (VYNT) United States $0.037B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.035B 0.00
IMMURON (IMRN) Australia $0.030B 0.00
Vallon Pharmaceuticals (VLON) United States $0.029B 0.00
ThermoGenesis Holdings (THMO) United States $0.029B 0.00
Prana Biotechnology (ATHE) Australia $0.028B 0.00
GeoVax Labs (GOVX) United States $0.028B 0.00
Seneca Biopharma (SNCA) United States $0.026B 0.00
Lexaria Bioscience (LEXX) Canada $0.024B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
Benitec Biopharma (BNTC) United States $0.021B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.015B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) United States $0.000B 0.00
Viridian Therapeutics (VRDN) United States $0.000B 0.00